1.Primary study on changes of serum proteomics in rabbit superior mesenteric artery occlusion shock.
Hong-Jie LI ; Rui-Li YAO ; Hui-Li WU ; Chang-Ying LI ; Shi-Xin WANG
Chinese Journal of Applied Physiology 2011;27(2):206-209
OBJECTIVETo explor the changes of serum proteomics in rabbits superior mesenteric artery occlusion (SMAO) shock as well as its possible effect in SMAO shock.
METHODSSMAO shock model in rabbits were induced by occlusion of the superior mesenteric artery, serum samples were obtained from rabbits before and after SMAO shock, proteins in samples were separated by two-dimensional electrophoresis(2-DE), spots in the 2-DE map were detected and evaluated by PDQuest software 8.0. The spots with different expression level were subjected to matrix assisted laser desorption/ionization-time of flight-time of flight-mass spectrometry (MALDI-TOF-TOF-MS) for identification, the protein database was searched to further characterized the differential proteins.
RESULTS19 differential protein spots were screened out in the 2-DE maps, 11 proteins were up-regulated and 8 proteins were down-regulated in SMAO shock rabbits' s serum. 4 of the 19 differential protein spots were selected for MALDI-TOF-TOF-MS study, and 2 of the 4 differential protein spots were identified satisfactoryly as paraoxonase and haptoglobin, which content were increased in rabbits' s serum after SMAO shock.
CONCLUSIONSerum proteomics of rabbit change remarkablely before and after SMAO shock, paraoxonase and haptoglobin may be associated with the compensation after SMAO shock.
Animals ; Arterial Occlusive Diseases ; blood ; complications ; Aryldialkylphosphatase ; metabolism ; Blood Proteins ; metabolism ; Female ; Haptoglobins ; metabolism ; Male ; Mesenteric Artery, Superior ; pathology ; Proteome ; metabolism ; Proteomics ; methods ; Rabbits ; Shock ; blood ; etiology
2.Effects of pomegranate flowers polyphenols on liver PON expression of diabetes combining non-alcoholic fat liver diseases rats.
Yuan-Yuan WEI ; Dong YAN ; Ayixianmu JAPAR ; Shan-Shan QU ; Akber Aisa HAJI ; Kerram PARHAT
Acta Pharmaceutica Sinica 2013;48(1):71-76
To investigate the protective effects and possible mechanism of pomegranate flowers polyphenols (PFP) on liver function of rats with diabetes combining non-alcoholic fat liver diseases, diabetes combining nonalcoholic fat liver disease model rats were established with high calorie feeding and small dose intraperitoneal injection of streptozotocin (STZ). Model rats were randomly divided into: model group, metformin group, pomegranate flowers polyphenols low, medium and high dose group (75, 150 and 300 mg x kg(-1)). After four weeks treatment, the levels of FPG, blood fat profiles and serum insulin, ALT, AST levels, SOD and MDA in the liver and serum separately were analyzed with biochemical methods. Paraoxonase (PON1 and PON3) mRNA and protein expression in liver were checked by RT-PCR and immunohistochemical method. Pathological changes of the liver were observed. FPG, IRI, non-HDL-C and transaminase significantly reduced and HDL-C raised in the each PFP dose group; Furthermore, compared with model group, fat drops in liver cells significantly reduced, antioxidant ability enhanced, PON1 mRNA and protein expression level in liver increased significantly. The protective effects of PFP against diabetes combining non-alcoholic fat liver diseases rats might through the increase liver PON1 mRNA and protein expression further enhanced the body antioxidant capacity and reduced IRI so as to ameliorate the rat hepatic steatosis.
Alanine Transaminase
;
blood
;
Animals
;
Aryldialkylphosphatase
;
genetics
;
metabolism
;
Aspartate Aminotransferases
;
blood
;
Blood Glucose
;
metabolism
;
Diabetes Mellitus, Experimental
;
metabolism
;
pathology
;
Fatty Liver
;
metabolism
;
pathology
;
Flowers
;
chemistry
;
Insulin
;
blood
;
Liver
;
metabolism
;
pathology
;
Male
;
Malondialdehyde
;
blood
;
metabolism
;
Non-alcoholic Fatty Liver Disease
;
Plants, Medicinal
;
chemistry
;
Polyphenols
;
isolation & purification
;
pharmacology
;
Punicaceae
;
chemistry
;
RNA, Messenger
;
metabolism
;
Random Allocation
;
Rats
;
Rats, Sprague-Dawley
;
Superoxide Dismutase
;
blood
;
metabolism
3.A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation.
Kyung Hyun CHO ; Jae Ryong KIM
Experimental & Molecular Medicine 2009;41(6):417-428
It has been hypothesized that blood infusion of reconstituted HDL (rHDL) is a possible therapeutic strategy for the treatment of coronary artery disese. To compare short-term anti-inflammatory activity of wildtype (WT) apoA-I and point mutants, each rHDL containing WT, V156K, or R173C was infused into apo-E deficient atherosclerotic mice. Each rHDL was injected via the tail vein at a dosage of 120 mg/kg of body weight in 0.4 ml of tris-buffered saline (TBS), and blood was then collected at 24 and 48 h post-injection. Although regression activity was observed in each of the rHDL infused groups, a 30% reduction in the lipid-stained area of the aortic sinus was observed in the V156K and R173C-rHDL groups when compared to that of the WT-rHDL group, and this reduction was well correlated with an approximately 60% reduction in the accumulation of macrophages in the lesion area. Additionally, the groups that received the V156K and R173C-rHDL treatments showed smaller increases in the GOT, GPT, interleukin-6, myeloperoxidase (MPO) and lipid hydroperoxide (LPO) serum levels than those that received the WT-rHDL treatment. In addition, the strongest serum paraoxonase and ferric reducing ability was observed in the V156K and R173C-rHDL groups. In vitro nitration and chlorination of apoA-I by MPO treatment revealed that V156K-rHDL and R173C-rHDL were less susceptible to chlorination. Furthermore, rHDL treatment inhibited cellular uptake of oxidized LDL by macrophage cells and the production of proatherogenic species in culture media. In conclusion, blood infusions of the rHDLs exerted in vivo regression activity with anti-inflammatory and antioxidant activity in apo-E deficient mice and THP-1 cells, especially in those that were treated with V156K and R173C apoA-I.
Animals
;
Anti-Inflammatory Agents/immunology/*therapeutic use
;
Apolipoprotein A-I/blood/genetics/immunology/*therapeutic use
;
Apolipoproteins E/genetics
;
Aryldialkylphosphatase/blood/metabolism
;
Atherosclerosis/*drug therapy
;
Cell Line
;
Cell Membrane Permeability
;
Cholesterol/blood/metabolism
;
Humans
;
Lipoproteins, HDL/genetics/immunology/*therapeutic use
;
Lipoproteins, LDL/metabolism
;
Macrophages/cytology
;
Mice
;
Mice, Inbred C57BL
;
Mice, Knockout
;
Oxidation-Reduction/*drug effects
;
Peroxidase/blood/metabolism
;
Point Mutation